Amity Island
Well-Known Member
- Relationship to Diabetes
- Type 1
More than £1 billion was spent on diabetes medicines in England in 2019/20, up 20% on the 2015/16 figure of £958m, NHS Business Services Authority (NHSBSA) data has revealed.
The rise to £1.2bn in 2019/20 was “driven by large increases in costs of antidiabetic drugs and insulin”, which resulted in “increased cost per person in 2019/20 [compared to] previous years”, NHSBSA said in a report on the prescribing for diabetes in England, published yesterday (November 5).
Antidiabetic drugs – generally prescribed to treat type 2 diabetes – accounted for £615 million of the total cost of diabetes medicines in 2019/20 and remain the “most prescribed treatment for diabetes”, totalling 42 million items in 2019/20.
The rise to £1.2bn in 2019/20 was “driven by large increases in costs of antidiabetic drugs and insulin”, which resulted in “increased cost per person in 2019/20 [compared to] previous years”, NHSBSA said in a report on the prescribing for diabetes in England, published yesterday (November 5).
Antidiabetic drugs – generally prescribed to treat type 2 diabetes – accounted for £615 million of the total cost of diabetes medicines in 2019/20 and remain the “most prescribed treatment for diabetes”, totalling 42 million items in 2019/20.
Cost of diabetes medicines up 20% in five years, NHS BSA data shows | Chemist+Druggist
More than £1 billion was spent on diabetes medicines in England in 2019/20, up 20% on the 2015/16 figure of £958m, NHS Business Services Authority (NHS BSA) data has revealed.
www.chemistanddruggist.co.uk